IntegraGen SA (EPA:ALINT)

France flag France · Delayed Price · Currency is EUR
0.170
0.00 (0.00%)
Apr 29, 2026, 4:28 PM CET
-68.61%
Market Cap 1.12M
Revenue (ttm) 5.33M
Net Income (ttm) -2.66M
Shares Out 6.62M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,813
Average Volume 6,704
Open 0.170
Previous Close 0.170
Day's Range 0.161 - 0.170
52-Week Range 0.115 - 0.732
Beta 0.39
RSI 47.18
Earnings Date Apr 30, 2026

About IntegraGen

IntegraGen SA provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France. The company’s genomic pharma services DNA sequencing for oncology and rare disease research; and NGS testing for cancer research. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; Ga... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 40
Stock Exchange Euronext Paris
Ticker Symbol ALINT
Full Company Profile

Financial Performance

In 2025, IntegraGen's revenue was 5.33 million, a decrease of -38.67% compared to the previous year's 8.70 million. Losses were -2.66 million, 940.6% more than in 2024.

Financial Statements

News

There is no news available yet.